Katie Gonzalez: Understanding the Hidden Risk of Inherited Thrombophilias
Katie Gonzalez, Marketing Communications Manager at Stago, shared National Blood Clot Alliance’s post on LinkedIn:
“Awareness and education can make such an important difference when it comes to blood clotting disorders.
Posts like this are a great reminder that understanding the mechanisms behind clotting and the risk factors that may otherwise go unnoticed, is an important part of improving awareness and supporting better patient outcomes.
Thank you to the National Blood Clot Alliance for continuing to make this information accessible.”
National Blood Clot Alliance shared a post on LinkedIn:
Protein C, protein S, and antithrombin deficiencies are rare inherited thrombophilias that can increase the risk of blood clots. These proteins are part of your body’s natural ‘brake system’ for clotting when one is deficient or isn’t working as it should, that balance can shift toward clot formation.
Because these deficiencies may not cause symptoms on their own, some people don’t learn they have one until after experiencing a blood clot or undergoing testing because of a family history.
Visit our website to learn more about inherited thrombophilias and other clotting disorders.
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day